Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rotrosen

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Pharmacological Research Communications|June 1, 1980
Antibiotics as inhibitors of enkephalin degradation by human brainL J Traficante, J Siekierski, J Rotrosen, et al.
Psychopharmacology Bulletin|January 1, 1991
Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's diseaseL A Adler, B Angrist, H Weinreb, et al.
Psychopharmacology|January 1, 1989
Neuroleptic-induced akathisia: a reviewL A Adler, B Angrist, S Reiter, et al.
Psychopharmacology Bulletin|January 1, 1987
Noradrenergic mechanisms in akathisia: treatment with propranolol and clonidineL Adler, B Angrist, E Peselow, et al.
The American Journal of Psychiatry|August 1, 1984
Side effects of scopolamine administrationM Serby, J Corwin, B Jordan, et al.
Neurology|August 1, 1980
Experimental dystonia induced by quaternary-chlorpromazineJ Rotrosen, M Stanley, C Kuhn, et al.
Psychopharmacology|January 1, 1980
Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor modelsM Stanley, A Lautin, J Rotrosen, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1996
Antioxidant treatment of tardive dyskinesiaJ Rotrosen, L Adler, J Lohr, et al.
Biological Psychiatry|April 15, 1990
Disorders of decision in affective disease: an effect of beta-adrenergic dysfunction?J Corwin, E Peselow, K Feenan, et al.
Psychopharmacology|January 1, 1985
Amphetamine response and relapse risk after depot neuroleptic discontinuationB Angrist, E Peselow, M Rubinstein, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Pharmacological Research Communications|June 1, 1980
Antibiotics as inhibitors of enkephalin degradation by human brainL J Traficante, J Siekierski, J Rotrosen, et al.
Psychopharmacology Bulletin|January 1, 1991
Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's diseaseL A Adler, B Angrist, H Weinreb, et al.
Psychopharmacology|January 1, 1989
Neuroleptic-induced akathisia: a reviewL A Adler, B Angrist, S Reiter, et al.
Psychopharmacology Bulletin|January 1, 1987
Noradrenergic mechanisms in akathisia: treatment with propranolol and clonidineL Adler, B Angrist, E Peselow, et al.
The American Journal of Psychiatry|August 1, 1984
Side effects of scopolamine administrationM Serby, J Corwin, B Jordan, et al.
Neurology|August 1, 1980
Experimental dystonia induced by quaternary-chlorpromazineJ Rotrosen, M Stanley, C Kuhn, et al.
Psychopharmacology|January 1, 1980
Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor modelsM Stanley, A Lautin, J Rotrosen, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1996
Antioxidant treatment of tardive dyskinesiaJ Rotrosen, L Adler, J Lohr, et al.
Biological Psychiatry|April 15, 1990
Disorders of decision in affective disease: an effect of beta-adrenergic dysfunction?J Corwin, E Peselow, K Feenan, et al.
Psychopharmacology|January 1, 1985
Amphetamine response and relapse risk after depot neuroleptic discontinuationB Angrist, E Peselow, M Rubinstein, et al.
Pageof 13